• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Janssen Therapeutics - Articles and news items

Janssen Pharmaceuticals Logo

FDA grants accelerated approval for SIRTURO™ (bedaquiline)

Industry news, News / 31 December 2012 / Johnson & Johnson

FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis…

Janssen Pharmaceuticals Logo

Edurant™ 96-Week Phase 3 safety and efficacy data presented

Industry news, News / 19 July 2011 / Janssen Therapeutics

Janssen Therapeutics, presented 96-week findings from two pivotal Phase 3 clinical trials…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +